Innovative therapeutics

Investors

IR Snapshot

NASDAQBMRN
Beta1.61
Shares Outstanding176.7M
Average Volume (10 days)1.2M
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($0.83)
Sales (TTM)$5.78
Book Value (MRQ)$15.88
Cash Flow (TTM)$0.17
Cash (MRQ)$7.86

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy16
 
Buy2
 
Hold2
 
Underperform0
 
Sell0
 

Recent Insider Transactions

V. Bryan Lawlis
(2,150)
Sell
Jun 27, 2018
Daniel K. Spiegelman
EVP, Chief Financial Officer
(472)
Sell
Jun 22, 2018
Brian Mueller
SVP, Corporate Controller
(2,491)
Sell
Jun 22, 2018
Brian Mueller
SVP, Corporate Controller
(654)
Sell
Jun 22, 2018
Daniel K. Spiegelman
EVP, Chief Financial Officer
(9,528)
Sell
Jun 22, 2018

Recent SEC Filings

Insider Buy/Sell
Jun 29, 2018
Insider Buy/Sell
Jun 26, 2018
Insider Buy/Sell
Jun 26, 2018
Insider Buy/Sell
Jun 26, 2018
Insider Buy/Sell
Jun 18, 2018

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information